Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting

INDIANAPOLIS, IN., Dec. 30, 2024 (GLOBE NEWSWIRE) — Board-certified medical oncologists, M. Sarfraz Nawaz, MD and Ruemu E. Birhiray, MD from community oncology practice Hematology Oncology of Indiana (HOI), a partner practice of American Oncology Network (AON) (OTCQX: AONC), presented clinically meaningful and socially impactful research findings at the 66^th American Society of Hematology (ASH) Annual Meeting and Exposition, held Dec. 7-10 in San Diego.

The ASH Annual Meeting is recognized as a premier event for hematology research, with more than 5,000 scientific abstracts submitted each year. Accepted abstracts undergo rigorous peer review, with selected presentations showcasing significant and innovative contributions to the field.

The following HOI physician-researchers presented at the conference:

• Dr. M. Sarfraz Nawaz
  • Presented and served as co-author of two studies:
    • Collaborative Strategies to Enhance Treatment and Integration of Cellular Therapies in Multiple Myeloma: Results from Nationwide Multiple Myeloma Patient and Provider Surveys
    • Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative

• • Co-authored Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: Key Findings from a Transformative Quality Improvement Initiative, published online in the November supplemental issue of Blood.

• • Moderated the ASH Satellite Symposium, Accelerating the Adoption of the Latest Evidence on Sequencing Therapies for Multiple Myeloma Across Practice Settings, held Dec. 6.

• Dr. Ruemu E. Birhiray
  • Co-authored three studies:
    • In-class Transition from Parenteral Bortezomib to Oral Ixazomib in Newly Diagnosed Multiple Myeloma: Analysis of US MM-6 By Number of Treatment Cycles Received.
    • Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): Results of the Safety Lead-in of the Phase 3 Olympia-1 Study.
    • A Systematic Review of 72 ASH Plenary and Late Breaking Abstracts for Racial Representation: A Health Equity Call to Action.

“Being selected to present research at the ASH Annual Meeting is a significant honor,” said Dr. M. Sarfraz Nawaz. “With thousands of submissions considered, these selected abstracts highlight vital advancements in cancer care. I congratulate my colleagues on their achievements and dedication to improving patient outcomes.”

“The evolving field of cancer research continually brings transformative findings that revolutionize patient care,” said Stephen “Fred” Divers, MD, AON chief medical officer. “Our physicians’ commitment to ongoing education and innovation reflects their dedication to advancing cancer care through impactful research that improves patient outcomes and expands access to quality care.”

###

American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 250 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Hematology Oncology of Indiana
Hematology Oncology of Indiana is a community-based medical oncology and hematology practice providing treatment for patients diagnosed with all types of cancer and blood disorders. Through compassionate care that centers around the patient, Hematology Oncology of Indiana strives to provide the best possible experience to patients and their families throughout the healthcare journey. Learn more at hematologyoncology.com.

Attachment

• Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting

CONTACT: Karen Riley Sawyer
American Oncology Network
541.221.1472
Karen.Sawyer@AONcology.com